Arbutus Biopharma Corporation
Arbutus Biopharma Corporation
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Intrahepatic and Peripheral Responses to Imdusiran (AB-729) in Chronic Hepatitis B | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 2 | 2025-09-11 | NCT06154278 | |
| Long-Term Follow-up Study for Subjects With CHB Previously Treated With Imdusiran (AB729) | Long Term Follow-up | Recruiting | Not stated | 2024-11-27 | NCT06277037 |